Invest now
Vaishali Pharma share price
You have to be logged in to add this to Watchlist.- ₹8.28(-1.19%)October 5, 2026 15:51:12 PM IST
- NSE
- BSE
- Vol : 217.31 K (NSE + BSE)Last 20 day avg : 182.10 K
Vaishali Pharma is trading -1.19% lower at Rs 8.28 as compared to its last closing price. Vaishali Pharma has been trading in the price range of 8.95 & 8.22. Vaishali Pharma has given -2.78% in this year & -1.76% in the last 5 days. Vaishali Pharma has TTM P/E ratio 9.95 as compared to the sector P/E of 33.86.The company posted a net profit of 1.49 Crores in its last quarter.Listed peers of Vaishali Pharma include Sun Pharmaceutical Industries (-1.55%), Divi's Laboratories (-0.88%), Torrent Pharmaceuticals (-0.14%).The Mutual Fund holding in Vaishali Pharma was at -% in . The MF holding has - from the last quarter. The FII holding in Vaishali Pharma was at 0.02% in 17 May 2024. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 05 Oct 2026, 08:23 PM IST
- BetaMedium volatility1.00Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.27The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation-0.59The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Vaishali Pharma Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,782.00 | -1.55 | 4,27,551.42 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 9,212.85 | -0.88 | 2,44,572.22 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,755.15 | -0.14 | 1,80,864.15 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,334.00 | -0.95 | 1,07,768.31 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,138.50 | -0.59 | 1,13,565.81 | 21.19 | 4.24 | 0.09 | 14.22 |
Vaishali Pharma Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-08-14 | Quarterly Results & Others |
| 2026-07-08 | To consider Fund Raising |
| 2026-07-02 | Fund Raising & Others |
| 2026-05-30 | Audited Results & Others |
| 2026-02-13 | Quarterly Results & Others |
About the company Vaishali Pharma
- IndustryBiotechnology & Drugs
- ISININE972X01022
- BSE Code
- NSE CodeVAISHALI
Vaishali Pharma Limited is an India-based pharmaceutical company. The Company is in the pharmaceutical business, mainly dealing in active pharmaceutical ingredients, pharmaceutical formulations, surgical products, and veterinary supplements, operating in domestic and export markets. Its product categories include active pharmaceutical ingredients (APIs), formulation brands, formulations, herbal, nutraceutical, oncology, surgical, and veterinary. The Company has manufactured and exported approximately 250 formulations and specializes in manufacturing tailor-made formulations. It offers APIs, including antibiotics, anti-ulcer, anti-inflammatory/analgesic/ anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, antiviral, antifungal, skeletal muscle relaxant, and anthelmintic drugs, excipients, topical steroids, corticosteroids, and enzymes. It has a global presence in Asia & Pacific, Africa, the Commonwealth of Independent States, America, and the Middle East.
Vaishali Pharma Share Price FAQs
Vaishali Pharma is trading at 8.28 as on Mon Oct 05 2026 10:21:12. This is -1.19% lower as compared to its previous closing price of 8.38.
The market capitalization of Vaishali Pharma is 111.78 Cr as on Mon Oct 05 2026 10:21:12.
The 52 wk high for Vaishali Pharma is 12.00 whereas the 52 wk low is 4.75
Vaishali Pharma can be analyzed on the following key metrics -
- TTM P/E: 9.95
- Sector P/E: 33.86
- Dividend Yield: 0.00%
- D/E ratio: -
Vaishali Pharma reported a net profit of 4.03 Cr in 2026.
Quick Links
EQUITY QUICK LINKS
Vaishali Pharma QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.